In 2016, I made a commitment not a New Years resolution, but a full restructuring of my life
Individual results with any GLP-1 medication, whether branded or compounded, vary based on numerous factors including adherence, lifestyle modifications, baseline health status, and individual physiology
Pairing this with ongoing lifestyle changes can help support lasting results
The FDA removed semaglutide from the drug shortage list in February 2025 and tirzepatide in October 2024, which restricted 503B outsourcing facilities from large-scale compounding
doi: 10.3389/fphar.2026.1736380 Received 10 November 2025 Revised 20 January 2026 Accepted 21 January 2026 Published 10 February 2026 Volume 17 - 2026 Edited by Madhusudan Prasad Singh, All India Institute of Medical Sciences Raipur, India Reviewed by Hemasri Velmurugan, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), India Prachi Arunima, All India Institute of Medical Sciences Raipur, India Updates Copyright 2026 Wali, Rangraze, Khan, Mufti, El-Tanani and Rizzo
